• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Kidney J . Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study

tetano

Editor, Senior Moderator
Clin Kidney J


. 2020 May 9;13(3):340-346.
doi: 10.1093/ckj/sfaa083. eCollection 2020 Jun.
Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study


Daqing Hong[SUP] 1 [/SUP], Lin Long[SUP] 2 [/SUP], Amanda Y Wang[SUP] 3 4 5 [/SUP], Yu Lei[SUP] 6 [/SUP], Yun Tang[SUP] 1 [/SUP], Jia Wei Zhao[SUP] 7 [/SUP], Xiaofei Song[SUP] 3 4 5 [/SUP], Yanan He[SUP] 3 4 5 [/SUP], Ergang Wen[SUP] 1 [/SUP], Ling Zheng[SUP] 1 [/SUP], Guisen Li[SUP] 1 [/SUP], Li Wang[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than 3 million patients globally. Previous data from Wuhan city showed that acute kidney injury (AKI), proteinuria and hematuria occurred frequently in patients with severe COVID-19. However, the prevalence of kidney injury in milder cases remains unclear.
Methods: This retrospective study included two major consecutive cohorts of COVID-19 patients in Sichuan Province. Baseline characteristics, laboratory data including renal function, proteinuria and dipstick hematuria, and other laboratory parameters were collected. A subgroup of patients was followed up for 2-4 weeks to evaluate the short-term outcome of renal impairment.
Results: Overall, 168 COVID-19-positive patients were included in the study. The majority of patients (79.7%) were diagnosed with mild or moderate disease. Half of patients presented with fever; however, in The Tibetan cohort, fever only occurred in 13.4% of patients. On hospital admission, proteinuria and dipstick hematuria were noted in 18.4% and 17.4% of patients, respectively, while AKI only occurred in one patient. Further analysis showed that severe or critical COVID-19 was associated with higher risk of proteinuria [relative risk (RR) 7.37, 95% confidence interval (CI) 2.45-22.18, P = 3.8 ? 10[SUP]-4[/SUP]] and dipstick hematuria (RR 8.30, 95% CI 2.69-25.56, P = 2.3 ? 10[SUP]-4[/SUP]). Proteinuria, dipstick hematuria, or the combination of proteinuria and hematuria could significantly predict severe or critical severe COVID-19.
Conclusions: Proteinuria and dipstick hematuria are not uncommon in patients with COVID-19 infection, especially in severe or critical cases.

Keywords: COVID-19; acute kidney injury.
 
Back
Top Bottom